james l tyree  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in james l tyree former vice chairman of the board at innoviva inc view full profile are you james l tyree claim your profile   sign up for equilar atlas and view james l tyrees full profile with equilar atlas you can identify corporate executives in james l tyrees network and community follow changes in james l tyrees employment and moneyinmotion connect with james l tyree through your network of contacts james l tyrees executive work history past to view james l tyrees complete executive work history sign up now age      james l tyrees biography james l tyree has served as a director of the company since october  since  mr tyree has served as cofounder and managing partner of tyree  dangelo partners a private equity investment firm prior to founding tyree  dangelo partners mr tyree was president of abbott biotech ventures a subsidiary of abbott laboratories focused on investments in early stage pharmaceuticals and biologics prior to that mr tyree held numerous executive positions at abbott including executive vice president global pharmaceuticals senior vice president global nutrition corporate vice president pharmaceutical and nutritional products group bus  read more james l tyree has served as a director of the company since october  since  mr tyree has served as cofounder and managing partner of tyree  dangelo partners a private equity investment firm prior to founding tyree  dangelo partners mr tyree was president of abbott biotech ventures a subsidiary of abbott laboratories focused on investments in early stage pharmaceuticals and biologics prior to that mr tyree held numerous executive positions at abbott including executive vice president global pharmaceuticals senior vice president global nutrition corporate vice president pharmaceutical and nutritional products group business development and divisional vice president and general manger japan prior to rejoining abbott in  mr tyree was the president of sugen inc and held management positions in bristolmyers squibb pfizer and abbott mr tyree serves as a director of innoviva inc and chemocentryx inc the board considered mr tyrees experience and expertise within the following areas relevant to the company and its business in concluding that he should serve on the board healthcare acquisitions corporate management commercial operations commercial strategy and board and board committee experience mr tyree holds a bs degree in psychology and forensic studies and a mba from indiana university source depomed inc on    sign up for equilar atlas and view james l tyrees full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like james l tyree more specifically youll be able to identify corporate executives in james l tyrees network and community follow changes in james l tyrees employment and moneyinmotion connect with james l tyree through your network of conections view full profile   search for over  executive profiles bio example james l tyree popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith elon r musk ceo and chairman tesla daniel a dematteo executive chairman gamestop corp david j oconnor president and ceo the madison square garden company × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   ccxi james l tyree insider trades for chemocentryx inc x tweet share this bulletin get news bulletins by email bulletin us stock benchmarks tilt lower early monday » investor alert new york markets close in market snapshot winners and losers expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close chemocentryx inc nasdaq ccxi go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus chemocentryx inc market open  real time quotes jul    am ccxi quoteszigmancomposite   change   volume volume  real time quotes quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual james l tyree mr james l tyree is cofounder  managing partner at tyree  dangelo partners llc independent director at chemocentryx inc and a member at the chicago council on global affairs he is on the board of directors at chemocentryx inc he cofounded tyree  dangelo partners in  mr tyree was previously employed as executive vice presidentpharmaceutical products by abbott laboratories president by abbott biotech ventures inc and president by sugen inc he also served on the board at tap pharmaceutical products inc mr tyree holds an mba and undergraduate degree in psychology and forensic studies from indiana university transactions date shares transaction value     derivativenonderivative trans at  per share      award at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives dr thomas j schall chairman president  chief executive officer ms susan m kanaya cfo secretary cao  principal accounting officer dr petrus bekker chief medical officer dr rajinder singh senior vice presidentresearch dr markus j cappel treasurer  chief business officer dr henry k mckinnell independent director mr thomas a edwards independent director dr joseph m feczko independent director dr roger c lucas lead independent director mr james l tyree independent director mr geoffrey m parker independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york open marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest acalmaine shares down  in early trade aif you can’t resist the lure of bottomfishing this market at least follow these five rules abreakingdow struggles to take flight as wall street focuses on earnings fed ahead apetmeds stock soars  to record high after q results anvidia stock price target raised to  from  at canaccord genuity asp  opens virtually flat adow jones industrial average down  points anasdaq composite index relatively unchanged aamericans in this field have the highest rate of divorce by age  astocks see flat open halliburton and google set to report earnings ait’s the ninth inning in this part of the new york realestate market aopec considers crackdown on output deal laggards ahuntington bancshares upgraded to buy from neutral at hilliard lyons athese wealthy parents spend  for summer camps so their kids can be ‘normal’ axerox stock price target raised to  from  at barclays axerox upgraded to equal weight from underweight at barclays awhy you’re more likely to die in an accident during the summer months athe dark side of cruises acaterpillars stock surges after bmo capital says business has passed the lows aus stock market could get powerful tailwind from weaker dollar morgan stanley loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  james l tyree  board of directors  depomed james l tyreemanaging partner tyree  d’angelo partners mr tyree has served as director of depomed since october  mr tyree is the cofounder and managing partner of tyree  d’angelo partners a private equity investment firm prior to founding tyree  d’angelo partners in  mr tyree was president abbott biotech ventures a subsidiary of abbott laboratories focused on investments in early stage pharmaceuticals and biologics before that mr tyree held numerous executive positions at abbott including corporate vice president pharmaceutical and nutritional products group business development senior vice president global nutrition and executive vice president global pharmaceuticals prior to rejoining abbott in  mr tyree was the president of sugen inc and held management positions in bristolmyers squibb pfizer and abbott mr tyree serves as a director of innoviva inc and chemocentryx mr tyree received bs degrees in psychology and forensic studies and a mba from indiana university about us management arthur j higgins sharon d larkin matthew m gosling august j moretti srinivas g rao thadd m vargas board of directors james p fogarty karen a dawes arthur j higgins louis j lavigne jr william t mckee gavin t molinelli robert g savage peter d staple james l tyree compliance contact us directions home about us products pipeline technology clinical trials investors careers sitemap contact us a growing specialty pharmaceutical company  depomed inc    all rights reserved terms of use privacy policy website design hane chow inc apldep rev  james l tyree executive profile  biography  bloomberg july    am et capital markets company overview of tyree  dangelo partners snapshotpeople  overviewboard memberscommittees executive profile james l tyree cofounder and managing partner tyree  dangelo partnersagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships background mr james l tyree also known as jim serves as the cofounder and managing partner of tyree  dangelo partners since  mr tyree is an advising founder at lionbird ventures ltd mr tyree is the founder of lionbird ventures ltd and served as its managing director and chief executive officer he founded lionbird ventures ltd in  he serves as an advisor at starboard value lp mr tyree served as the chief executive officer of dermatology medical partners  llc until may   he is a special advisor to the chancellor of uc davis sacramento he has a distinguished career in health care spanning more than  years with senior management positions at abbvie abbott laboratories bristolmeyers squibb and pfizer previously he served as executive vice president and president of abbott biotech ventures inc and abbvie biotech ventures inc he has a distinguished  year career served as an executive vice president of pharmaceutical products group of abbott laboratories from  to august   where he held senior executive roles in the pharmaceutical nutrition and international divisions he served as the president of abbott nutrition international of abbott laboratories and vice president of global licensingnew business development since  he served as senior vice president of pharmaceutical operations for abbott laboratories from  to  within the pharmaceutical operating division he was integrally involved in every major transaction executed by the company mr tyree identified and analyzed more than one thousand pharmaceutical inlicensing and outlicensing opportunities for abbott and drove a substantial number of them to successful transactions he was also directly responsible for establishing and managing abbott global nutrition previously he served as senior vice president of abbott nutrition international from april  to  and senior vice president global nutrition since  mr tyree served as divisional vice president of global licensingnew business development from  to  and as divisional vice president and general manager abbott international division from  to  he served as vice president of global licensingnew business development at abbott laboratories since  at abbott laboratories he served as corporate vice president pharmaceutical and nutritional products group business development he served as president of abbott biotechnology ventures until march   he served at triangle pharmaceuticals inc he served as business analyst of abbott from  to  and corporate officer since  he rejoined abbott in  he served as president of sugen inc mr tyree led the companys initial public offering in  he served management positions at bristolmyers squibb pfizer and abbott he serves as a cochairman of the global health policy roundtable he has been the chairman of the board at genelux corporation since may  mr tyree has been a genelux board member or observer since  he served as the chairman of illinois biotechnology industry organization he served as vice chairman innoviva inc from march   to june   and served as its director from june   to june   he has been an independent director of depomed inc since october   he serves as director of tap pharmaceuticals theravance and ibio institute he has been a director of chemocentryx inc since june   he serves as a director of sonarmed he serves as a member of the advisory boards of the polsky center of entrepreneurship at the university of chicago and the kellogg center for biotechnology at northwestern university he serves as member of richard m daleys chicago mayors council of technology advisors he serves as a member of the advisory board at the university of chicago booth graduate school of business and a member of the chicago council on global affairs he has an extensive senior leadership and operational experience in the pharmaceutical and biotechnology industries he has distinguished career in health care heading global pharmaceutical products and business development in the pharmaceutical industry mr tyree has two bachelors degrees in psychology and forensic studies and a masters degree in business administration from kelley school at indiana universityread full background corporate headquarters  north michigan avenuechicago illinois united statesphone fax  board members memberships directoribio institutepresentdirectorchemocentryx incpresentchairman of the boardgenelux corporationpresentindependent directordepomed inc education ba indiana university bloomingtonbs indiana university bloomingtonmba kelley school of business other affiliations innoviva inctriangle pharmaceuticals incabbott laboratoriesdepomed incchemocentryx incindiana university bloomingtonillinois biotechnology industry organizationkelley school of businessgenelux corporationibio instituteabbvie biotech ventures inclionbird ventures ltddermatology medical partners llc annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation there is no total compensation data available request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact tyree  dangelo partners please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close chemocentryx announces appointment of james l tyree to the companys board of directors nasdaqccxi facebook google linkedin twitter email rss jun   previous release  next release pdf add to briefcase file is in briefcase chemocentryx announces appointment of james l tyree to the companys board of directors mountain view calif june   globe newswire  chemocentryx inc nasdaqccxi announced today that james l tyree has been appointed to the companys board of directors effective immediately and that it has increased the size of its board from six to seven mr tyree is a former executive vice president of abbott laboratories and brings to the chemocentryx board extensive senior leadership and operational experience in the pharmaceutical and biotechnology industries we are privileged to have jim join the chemocentryx board of directors said thomas j schall phd president and chief executive officer chemocentryx his distinguished career in health care heading global pharmaceutical products and business development in the pharmaceutical industry make him a great addition i am honored to join the chemocentryx board stated mr tyree chemocentryx has an impressive track record advancing novel medicines into clinical development and i look forward to contributing my perspective and insights as the company further advances toward commercialization during the last fourteen years mr tyree has held numerous executive positions at abbott laboratories including corporate vice president pharmaceutical and nutritional products group business development senior vice president global nutrition and executive vice president global pharmaceuticals he retired as president abbott biotechnology ventures on march   prior to joining abbott mr tyree was the president of sugen inc a biotechnology company focused on oncology earlier in his career mr tyree held management positions in bristolmyers squibb pfizer and abbott over his entire career he was a fourtime expatriate living and working over six years in latin america and seven years in japan mr tyree is a member of the advisory board of the university of chicago booth graduate school of business a member of the chicago council on global affairs and cochairman of the global health policy roundtable mr tyree also serves as a director for a number of privately held companies mr tyree earned bachelors degrees in psychology and forensic studies and a masters degree in business administration from indiana university about chemocentryx chemocentryx inc is a clinicalstage biopharmaceutical company focused on discovering developing and commercializing orallyadministered therapeutics that target the chemokine and chemoattractant systems in order to treat autoimmune diseases inflammatory disorders and cancer the chemokine system is a biological network that regulates inflammation via a collection of secreted chemokine molecules or ligands and their specific cell surface receptors based on its proprietary drug discovery and drug development platform chemocentryx has generated multiple clinical and preclinicalstage programs each targeting distinct chemokine and chemoattractant receptors with different small molecule compounds the companys most advanced drug candidate vercirnon also known as traficeten ccx or gsk a specific ccr inhibitor completed a multinational clinical trial called protect in patients with moderatetosevere crohns disease where it demonstrated the ability to induce a clinical response and to maintain clinical remission and is now in phase iii clinical development the companys lead independent drug candidate ccx a ccr inhibitor has been shown to be safe and well tolerated while demonstrating clinical activity on glycemic indices in a phase ii clinical trial in type  diabetics and is now in phase ii clinical development for the treatment of diabetic nephropathy other clinical programs include ccx also known as gsk a ccr inhibitor which successfully completed a phase ii clinical trial for the treatment of rheumatoid arthritis and ccx a car inhibitor in phase ii clinical development for the treatment of antineutrophil cytoplasmic antibody ancaassociated vasculitis chemocentryx also has several programs in advanced preclinical development forwardlooking statements chemocentryx cautions you that statements included in this press release that are not a description of historical facts are forwardlooking statements words such as may could will would should expect plan anticipate believe estimate intend predict seek contemplate potential or continue or the negative of these terms or other comparable terminology are intended to identify forwardlooking statements these statements are based on the companys current beliefs and expectations the inclusion of forwardlooking statements should not be regarded as a representation by chemocentryx that any of its plans will be achieved actual results may differ from those set forth in this release due to the risk and uncertainties inherent in the chemocentryx business and other risks described in the companys filings with the securities and exchange commission you are cautioned not to place undue reliance on these forwardlooking statements which speak only as of the date hereof and chemocentryx undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof further information regarding these and other risks is included under the heading risk factors in chemocentryxs periodic reports filed with the securities and exchange commission sec including chemocentryxs annual report on form k for the year ended december   and quarterly report on form q for the threemonth period ended march   which are available from the secs website wwwsecgov and on chemocentryxs website wwwchemocentryxcom under the heading investors all forwardlooking statements are qualified in their entirety by this cautionary statement this caution is made under the safe harbor provisions of section e of the private securities litigation reform act of  ccxi — g   contact susan m kanaya senior vice president finance and chief financial officer or markus j cappel phd chief business officer  investorchemocentryxcom burns mcclellan media inquiries justin jackson  jjacksonburnsmccom source chemocentryx inc news provided by acquire media james l tyree  marlinton wv  company information products resources my account talk to a db advisor  business directory wv marlinton nonclassifiable establishments nonclassifiable establishments james l tyree j james l tyree claim this business  th ave apt  marlinton wv  get directions   business info founded  incorporated annual revenue  employee count  industries nonclassifiable establishments contacts contact business your email address subject message send message company summary since  james l tyree has been providing nonclassifiable establishments from marlinton verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   j view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocalcom mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc  all rights reserved tyree  dangelo partners  investment partners home about us team investments owners intermediaries investment partners james l tyree managing partner jtyreetdpfundcom james has a distinguished career in health care spanning more than thirty years his accomplishments are well recognized as an investor operating executive and entrepreneur during the last fourteen years he held numerous executive positions at abbott including corporate vice president pharmaceutical and nutritional products group business development senior vice president global nutrition and executive vice president global pharmaceuticals he retired as president abbott biotech ventures in his last three positions prior to retiring from abbott james reported to the chairman and chief executive officer from  to  james was a significant contributor to abbotts most defining endeavors within the pharmaceutical operating division james was integrally involved in every major transaction executed by the company including the acquisitions of basf pharmaceuticals kos pharmaceuticals solvay pharmaceuticals and piramal health solutions he was also responsible for the restructuring of tap abbotts highly successful joint venture with takeda chemicals of japan in addition james identified and analyzed more than one thousand pharmaceutical inlicensing and outlicensing opportunities for abbott and drove a substantial number of them to successful transactions james was also directly responsible for establishing and managing abbott global nutrition abbotts second largest and profitable operating division prior to joining abbott james was the president of sugen inc a biotechnology company focused in oncology james led the companys initial public offering in  and subsequently shaped the company to make it an attractive acquisition target the company was acquired by pharmacia in  earlier in his career james held management positions in bristolmyers squibb pfizer and abbott over his entire career he is a four time expatriate living and working six and a half years in latin america and seven years in japan james is a member of the advisory board of the university of chicago graduate school of business booth he is a special advisor to the chancellor of uc davis sacramento james serves as an independent director of depomed sonarmed genelux chemocentryx and theravance james earned his mba from the kelley school of business at indiana university as well as two bachelor degrees in psychology and forensic studies from indiana university enzo a dangelo managing partner edangelotdpfundcom enzo brings almost two decades of leading private equity investment and corporate finance experience he previously worked at norwest equity partners which managed  billion of investment capital from minnesota wind point partners which managed  billion of investment capital from illinois and michigan and american securities which managed  billion of investment capital from new york prior to entering the private equity industry enzo focused on corporate finance merger  acquisition advisory and lending for private equity investments while at credit suisse investment banking in new york enzo holds an mba with honors from the kellogg school of management at northwestern university is a chartered financial analyst and received an undergraduate business degree with honors from the richard ivey school of business at the university of western ontario michael j tyree managing partner mtyreetdpfundcom michael has over one and a half decades of leading private equity investment and corporate finance experience he previously worked at flexpoint ford which managed  billion of investment capital from illinois and new york and was one of the initial investment professionals hired michael also worked at stark investments in wisconsin at the time a  billion hedge fund investing in equity securities prior to entering private equity michael worked in corporate finance and merger  acquisition advisory for different sized healthcare companies while at lazard investment banking in new york michael holds an mba from the kellogg school of management at northwestern university and an undergraduate double major in economics and biological sciences with phi beta kappa and student marshal distinction from the university of chicago ryan b griffith vice president rgriffithtdpfundcom ryan brings almost a decade of private equity and investment banking experience he previously worked at prism capital which managed almost  million of investment capital from chicago prior to entering the private equity industry ryan focused on corporate finance merger  acquisition advisory while at houlihan capital in chicago ryan holds an mba from the kellogg school of management at northwestern university and received an undergraduate finance degree from augustana college nathan c miller vice president nmillertdpfundcom nathan brings almost a decade of private equity and investment banking experience he previously worked at chs code hennessy  simmons capital which managed  billion of investment capital from chicago nathan also worked in corporate finance and merger  acquisition advisory at goldman sachs  co in new york and lincoln international in chicago nathan holds an mba from the kellogg school of management at northwestern university and received an undergraduate business degree with distinction from the kelley school of business at indiana university     team overview investment partners james l tyree enzo a d’angelo michael j tyree ryan b griffith nathan c miller executive partners advisory partners portfolio company executives administration  finance  n michigan ave suite  chicago il  contact us viewprint website in pdf copyright   tyree  dangelo partners all rights reserved james l tyree exec vp  pharmaceutical products group abbott laboratories a publisher of business information since         search business search executive   advanced search   sign in    hints profile of james tyree   james tyree   exec vp  pharmaceutical products group  abbott laboratories   james tyree email  please login   company name  abbott laboratories   company website  wwwabbottcom   company address   abbott pk rd abbott park ilunited states   james tyree profile  exec vp  pharmaceutical products group  abbott laboratories   james tyree biography  james tyree is senior vice president global nutrition tyree first joined abbott from  until  as a business analyst for a year he rejoined the company in june  and has been in various management positions including divisional vice president and general manager for abbotts international division in japan he recently served as vice president global licensingnew business development in the pharmaceutical products division he assumed his current role in april prior to rejoining abbott in  tyree was president of sugen inc a biotechnology startup company and held various leadership positions at other pharmaceutical companieshe serves on the board of directors for tap pharmaceuticals a joint venture between abbott and takeda pharmaceutical company limited he is a member of the advisory boards of the polsky center of entrepreneurship at the university of chicago and the kellogg center for biotechnology at northwestern university he is a member of richard m daleys chicago mayors council of technology advisors formerly chairman he is also chairman of the board of directors of the illinois biotechnology industry organizationhe earned bachelors degrees in psychology and forensic studies and a masters degree in business administration from indiana university   james tyree colleagues  name title email david owen board dir please login laura schumacher exec vp general counsel sec please login william daley board dir please login john landgraf sr vp  global pharmaceutical manufacturing supply please login richard gonzalez dir pres coo please login             home    about us    product information     subscription    list builder     executive list     email lists     contact us    site map    browse directory      �  walkerss research  a publisher of business information since  all rights reserved james l tyree  chicago il  intelius sign in we found james l tyree in chicago il james l tyree intelius found that james l tyree is a male between  and  years old from chicago il we have connected them to  addresses  phones and  relatives or associates get report now age james l tyree is in his s james has lived in chicago il wilmington de new town pa jamess relatives michael tyree kathryn tyree renee tyree james l tyree zodiac signpisces gendermale professional status senior vice president at abbott laboratories company get report now want to know more about james get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about james or use our people search engine to find others get background check on james l tyree get a criminal check on james l tyree get a public record report on james l tyree get a people search report on james l tyree james l tyrees contact information known cities lived in find out where james l tyree has lived as well as james l tyrees phone numbers and email addresses james l tyree has lived in  states illinois address for james l tyree  w b a chicago il has lived in chicago il wilmington de get full address report phone numbers associated with james l tyree    chicago il    chicago il    phoenix az get full phone report email addresses associated with james l tyree jecom jenet get email report james l tyrees professional information information regarding james l tyrees professional history find out previous places james l tyree has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act james l tyree has worked at  place company abbott laboratories company title senior vice president james l tyrees experience title senior vice president company abbott laboratories company job details abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare with a portfolio of leading sciencebased offerings in diagnostics medical devices nutritionals and branded generic pharmaceuticals abbott serves people in more than  countries and employs approximately  people additional professional information on james l tyree see james l tyrees linkedin profile james l tyrees social network and potential email matches find out potential social network profiles and potential email usernamed for james l tyree james l tyrees known social networks and potential email matches find all of james l tyrees social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches james tyree username matches jamestyree tyreejames jamestyree tyreejames jamestyree tyreejames jamestyree tyreejames jtyree popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches j tyree intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here board of directors  genelux about genelux about geneluxboard of directors management team advisory boards genelux corporation board of directors                      james l tyree chairman james l tyree has achieved a distinguished career in health care spanning more than thirty years his accomplishments are well recognized as an investor operating executive and entrepreneur during the last fourteen years he has held numerous executive positions at abbott including corporate vice president pharmaceutical and nutritional products group business development senior vice president global nutrition and executive vice president global pharmaceuticals he retired as president abbott biotechnology ventures in his last three positions prior to retirement mr tyree reported to the chairman and chief executive officer prior to joining abbott mr tyree was the president of sugen inc a biotechnology company focused in oncology mr tyree led the company’s initial public offering in  and subsequently shaped the company to make it an attractive acquisition target the company was acquired by pharmacia in  earlier in his career mr tyree held management positions in bristolmyers squibb pfizer and abbott over his entire career he is a four time expatriate living and working six and a half years in latin america and seven years in japan mr tyree is a member of the advisory board of the university of chicago graduate school of business booth he is also a member of the chicago council on global affairs and cochairman of the global health policy roundtable he is past chairman of the board of directors of the illinois biotechnology industry organization mr tyree is an independent director for sonarmed a privately held developer and manufacturer of critical care respiratory monitoring technologies mr tyree joined the genelux corporation board of directors in may  mr tyree earned bachelor degrees in psychology and forensic studies and a master’s degree in business administration from indiana university george a vandeman jd vice chairman george vandeman an attorney and former senior executive at amgen has enjoyed a long and distinguished career spanning corporate development product licensing corporate transactions corporate governance and strategic planning mr vandeman retired in  after five years at amgen as senior vice president general counsel and chairman of the company’s operating committee during his tenure at amgen he was responsible for the corporate development and product licensing groups the company’s legal department as well as mergers and acquisitions and product licensing activities immediately prior to joining amgen mr vandeman was a senior partner and head of mergers  acquisitions for the international law firm of latham  watkins where he worked for nearly three decades representing bidders targets and financial advisors in corporate control transactions and advising boards of directors as to ma and corporate governance matters during his long career at latham  watkins george vandeman represented many wellknown television entertainment and corporate clients including marvin davis in ma matters and ted turner in his bid for cbs his acquisition of mgmua and subsequent sale of certain mgm assets he also represented michael jackson in his consideration to take his music publishing company public the special committee of the board of directors of imagine films entertainment in connection with the purchase of that company by director ron howard and producer brian grazer and nestlé usa in connection with certain acquisitions and divestitures among others since his retirement from amgen he has been a principal in vandeman  co a private investment firm and remained active in the corporate arena including owning a restaurant group on joint base pearl harbor hickam mr vandeman is also a member and past chair of the board of councilors at the university of southern california law school he received his ba degree in  and his jd degree in  from the university of southern california john thomas ma mba phd dr thomas served as the company’s first chief financial officer before leaving the post in  he has been a member of the board of directors since august  he is currently dean of the school of business and management at la sierra university in riverside california where he teaches finance economics and entrepreneurship a position he has occupied since july  dr thomas holds mba degrees in finance and marketing an ma in political economy and a phd in economics and politics he has received numerous awards honoring his success as a passionate teacher who motivates students to seek and achieve excellence among them the freedom foundation’s leavey award for excellence in private enterprise education  the zapara award to teaching excellence  and the riverside chambers of commerce hero award for community leadership  ronald roy a simus dr ronald roy a simus joined genelux corporation as the company’s first investor in  when the company was first attempting to build its initial scientific discoveries into a biomedical research and development company since this time dr simus has been involved with the growth and evolution of the company including participating in the company’s management corporate strategy fundraising and operations today he serves as the company’s interim secretary its vice president of investor relations and investments and is also a member of the company’s board of directors dr simus holds a dds and an ms in orthodontics and dentofacial orthopedics from loma linda university thomas zindrick jd tom zindrick an experienced life sciences and biotechnology executive with a career spanning more than  years joined genelux corporation as president and ceo in may  mr zindrick retired from amgen inc in  after a distinguished  year career and has since served as ceo of amitech therapeutic solutions inc a la jolla california based discovery and drug development company focused on commercializing allosteric kinase inhibitors as well independent consultant to genelux corporation during his career at amgen he held positions of increasing responsibility including vice president associate general counsel and chief compliance officer as vice president associate general counsel mr zindrick led intellectual property licensing and regulatory law teams and served on crossfunctional business and product development teams these teams were responsible for acquisitions totaling over twenty billion dollars and the licensing and development of six therapeutic products and numerous clinical candidates as chief compliance officer he reported to the board of directors and led the corporate compliance program which oversaw the compliance activities of numerous company functions including product development manufacturing and marketing prior to joining amgen mr zindrick was an attorney at the dow chemical company mr zindrick received his jd from the university of illinois college of law and a ba in biology from north central college in naperville illinois billy j parrott billy parrott’s long and illustrious career in advertising marketing writing and directing began as a mail boy at mccann erickson advertising in less than  years he ultimately rose to creative supervisor at benton  bowles responsible for the creative output of over  the firm’s billings and winning every copywriting award in advertising on premier advertising accounts as crest toothpaste scope mouth wash hilton hotels oreo premium saltine crackers ritz crackers chips ahoy nestea vanquish headache remedy and coca cola his marketing career included consulting for time magazine where mr parrott developed the innovative groundbreaking and high revenue generating “magazine within the magazine” concept that is still a highly effective marketing tool for the print media he was also a marketing consultant to att roche pharmaceuticals sharp electronics jvc becton dichinson mead johnson and others mr parrott was ceo  cofounder of private networks inc a pioneer in the wireless telecommunication industry he a founder of american mobile satellite company renamed motient then later terrestar where he served over  years on the board of directors including the executive audit and compensation committees and as a member of the executive committee when it approved the formation and funding of xm satellite radio and msv ventures over the years billy parrott has earned distinction as an award winning movie producer director and writer having formed the film production company parrott and people he received the peabody award for directing the boy king a television movie depicting the childhood life of dr martin luther king starring oscar nominee howard rollins he directed and wrote from king to congress an award winning national television documentary on andy young’s successful bid for congress which premiered at the kennedy center  and numerous other documentaries and videos mr parrott enlisted in the united states air force serving four years prior to entering and graduating from oregon state university with bs in business administration he attended oregon state on a football scholarship under legendary hall of fame coach tommy prothro he still serves several boards including the american youth hostel peter kroll md dr peter kroll md is board certified in anesthesiology since  and board certified in pain management since  he is a founder owner and medical director of nashville tennesseebased comprehensive pain specialists the largest pain practice in the southeast with  multistate locations and over  employees specializing in the field of pain management dr kroll creates treatment and management plans for patients suffering from chronic pain resulting from a wide range of disorders diseases and complications throughout his time as a practicing physician he has directed over  clinical trials as a principal and sub investigator and authored multiple publications dr kroll graduated from loma linda university school of medicine in  in the top  of his class with academic recognition admission into the alpha omega alpha society  and through  completed his surgical internship  months of orthopedic residency and  years of anesthesiology residency at loma linda university medical center he then completed his interventional pain fellowship at wake forest university baptist hospital in  in  dr kroll graduated summa cum laude from southern adventist university collegedale tn with a ba in religion and a minor in chemistry albert röder phd dr albert röder joined genelux corporation in  after retiring from roche applied science as head of global rd and marketing support in february of that year he was elected to the board of directors of genelux corporation his distinguished year career in the pharmaceutical and diagnostics industries included several operative and leadership positions in research and development manufacturing marketing strategy and business development within international crossfunctional teams before joining roche dr röder worked for boehringer mannheim where he rose to head of research in enzymology proteinchemistry and chemistry then to head of the global product supply unit of its business unit biochemicals he holds a phd in organic chemistry from the university of tübingen in germany byron georgiou byron georgiou has had a long career in the private and public sector in business law and government service from  to  he served as one of ten bipartisan nationwide members on the financial crisis inquiry commission which conducted america’s official inquiry into the causes of the continuing financial economic and housing crises and reported its results to the president and congress httpfciclawstanfordedu byron currently oversees georgiou enterprises with wideranging interests including as chair president ceo and controlling shareholder of xtreme green electric vehicles inc wwwxgevcom manufacturer of lithium ion ironphosphate battery powered allelectric niche vehicles distributed worldwide lead investor and sole nonfounder independent director from  to  of health fusion wwwhealthfusioncom providing practice management and cloudbased healthcare information technology to us healthcare providers which was sold in  for up to  million to quality systems inc qsiinasdaq cofounder in  of and continuing advisor to corinthian capital group wwwcorinthiancapcom a new york and boston based middle market private equity fund director since  of genelux a clinical stage biopharmaceutical company that has developed a proprietary oncolytic virus based technology platform and deep pipeline of products wwwgeneluxcom director since  of nipd genetics a biotechnology company active in the field of designing developing and manufacturing noninvasive genetics tests wwwnipdcom former director of group aero wwwgroupaerocom which provided advanced engineering design and manufacturing services to the space commercial aerospace and defense markets former director of mortgage resolution partners a community advisory firm that assisted local governments in addressing the underwater mortgage crisis in america and over  year director and  cofounder with jack ford son of president gerald ford of infoplaceusa wwwinfoplaceusacom providing customer services at regional shopping centers nationwide byron has served since  on the advisory board of the harvard law school program on corporate governance wwwlawharvardeduprogramscorpgov which hosts the world’s leading blog on corporate governance and financial regulation from  to  he was of counsel to robbins geller rudman  dowd wwwrgrdlawcom and its predecessor law firms the world’s largest plaintiffs’ securities practice investigating and civilly prosecuting financial fraud with leadership roles in the historic litigations on behalf of victimized institutional investors at enron worldcom dynegy aoltimewarner and unitedhealth in  byron cofounded american partners capital group with dale hanson then ceo of the california public employees’ retirement system calpers the nation’s largest pension fund to meet the needs of institutional investors and investment managers with capital formation in a variety of alternative asset categories during the second of jerry brown’s four terms as california governor byron served as legal affairs secretary responsible for litigation by and against the governor judicial appointments liaison with the attorney general judiciary and state bar legal advice to the governor and members of his cabinet and exercise of the governor’s powers of extradition and clemency byron attended stanford university on a full alfred p sloan academic scholarship graduating with great distinction with an ab in political science as a participant in the honors program in social thought and institutions and received his jd magna cum laude from harvard law school aboutboard of directors management team advisory boards leadershiponcolytic virotherapy publications intellectual property technologyattacking cancer imaging therapies glonc vvet pipeline clinical trialsabout clinical trials clinical trials operations contactcareers copyright   genelux  disclaimer website by blausenmedia board of directors  genelux about genelux about geneluxboard of directors management team advisory boards genelux corporation board of directors                      james l tyree chairman james l tyree has achieved a distinguished career in health care spanning more than thirty years his accomplishments are well recognized as an investor operating executive and entrepreneur during the last fourteen years he has held numerous executive positions at abbott including corporate vice president pharmaceutical and nutritional products group business development senior vice president global nutrition and executive vice president global pharmaceuticals he retired as president abbott biotechnology ventures in his last three positions prior to retirement mr tyree reported to the chairman and chief executive officer prior to joining abbott mr tyree was the president of sugen inc a biotechnology company focused in oncology mr tyree led the company’s initial public offering in  and subsequently shaped the company to make it an attractive acquisition target the company was acquired by pharmacia in  earlier in his career mr tyree held management positions in bristolmyers squibb pfizer and abbott over his entire career he is a four time expatriate living and working six and a half years in latin america and seven years in japan mr tyree is a member of the advisory board of the university of chicago graduate school of business booth he is also a member of the chicago council on global affairs and cochairman of the global health policy roundtable he is past chairman of the board of directors of the illinois biotechnology industry organization mr tyree is an independent director for sonarmed a privately held developer and manufacturer of critical care respiratory monitoring technologies mr tyree joined the genelux corporation board of directors in may  mr tyree earned bachelor degrees in psychology and forensic studies and a master’s degree in business administration from indiana university george a vandeman jd vice chairman george vandeman an attorney and former senior executive at amgen has enjoyed a long and distinguished career spanning corporate development product licensing corporate transactions corporate governance and strategic planning mr vandeman retired in  after five years at amgen as senior vice president general counsel and chairman of the company’s operating committee during his tenure at amgen he was responsible for the corporate development and product licensing groups the company’s legal department as well as mergers and acquisitions and product licensing activities immediately prior to joining amgen mr vandeman was a senior partner and head of mergers  acquisitions for the international law firm of latham  watkins where he worked for nearly three decades representing bidders targets and financial advisors in corporate control transactions and advising boards of directors as to ma and corporate governance matters during his long career at latham  watkins george vandeman represented many wellknown television entertainment and corporate clients including marvin davis in ma matters and ted turner in his bid for cbs his acquisition of mgmua and subsequent sale of certain mgm assets he also represented michael jackson in his consideration to take his music publishing company public the special committee of the board of directors of imagine films entertainment in connection with the purchase of that company by director ron howard and producer brian grazer and nestlé usa in connection with certain acquisitions and divestitures among others since his retirement from amgen he has been a principal in vandeman  co a private investment firm and remained active in the corporate arena including owning a restaurant group on joint base pearl harbor hickam mr vandeman is also a member and past chair of the board of councilors at the university of southern california law school he received his ba degree in  and his jd degree in  from the university of southern california john thomas ma mba phd dr thomas served as the company’s first chief financial officer before leaving the post in  he has been a member of the board of directors since august  he is currently dean of the school of business and management at la sierra university in riverside california where he teaches finance economics and entrepreneurship a position he has occupied since july  dr thomas holds mba degrees in finance and marketing an ma in political economy and a phd in economics and politics he has received numerous awards honoring his success as a passionate teacher who motivates students to seek and achieve excellence among them the freedom foundation’s leavey award for excellence in private enterprise education  the zapara award to teaching excellence  and the riverside chambers of commerce hero award for community leadership  ronald roy a simus dr ronald roy a simus joined genelux corporation as the company’s first investor in  when the company was first attempting to build its initial scientific discoveries into a biomedical research and development company since this time dr simus has been involved with the growth and evolution of the company including participating in the company’s management corporate strategy fundraising and operations today he serves as the company’s interim secretary its vice president of investor relations and investments and is also a member of the company’s board of directors dr simus holds a dds and an ms in orthodontics and dentofacial orthopedics from loma linda university thomas zindrick jd tom zindrick an experienced life sciences and biotechnology executive with a career spanning more than  years joined genelux corporation as president and ceo in may  mr zindrick retired from amgen inc in  after a distinguished  year career and has since served as ceo of amitech therapeutic solutions inc a la jolla california based discovery and drug development company focused on commercializing allosteric kinase inhibitors as well independent consultant to genelux corporation during his career at amgen he held positions of increasing responsibility including vice president associate general counsel and chief compliance officer as vice president associate general counsel mr zindrick led intellectual property licensing and regulatory law teams and served on crossfunctional business and product development teams these teams were responsible for acquisitions totaling over twenty billion dollars and the licensing and development of six therapeutic products and numerous clinical candidates as chief compliance officer he reported to the board of directors and led the corporate compliance program which oversaw the compliance activities of numerous company functions including product development manufacturing and marketing prior to joining amgen mr zindrick was an attorney at the dow chemical company mr zindrick received his jd from the university of illinois college of law and a ba in biology from north central college in naperville illinois billy j parrott billy parrott’s long and illustrious career in advertising marketing writing and directing began as a mail boy at mccann erickson advertising in less than  years he ultimately rose to creative supervisor at benton  bowles responsible for the creative output of over  the firm’s billings and winning every copywriting award in advertising on premier advertising accounts as crest toothpaste scope mouth wash hilton hotels oreo premium saltine crackers ritz crackers chips ahoy nestea vanquish headache remedy and coca cola his marketing career included consulting for time magazine where mr parrott developed the innovative groundbreaking and high revenue generating “magazine within the magazine” concept that is still a highly effective marketing tool for the print media he was also a marketing consultant to att roche pharmaceuticals sharp electronics jvc becton dichinson mead johnson and others mr parrott was ceo  cofounder of private networks inc a pioneer in the wireless telecommunication industry he a founder of american mobile satellite company renamed motient then later terrestar where he served over  years on the board of directors including the executive audit and compensation committees and as a member of the executive committee when it approved the formation and funding of xm satellite radio and msv ventures over the years billy parrott has earned distinction as an award winning movie producer director and writer having formed the film production company parrott and people he received the peabody award for directing the boy king a television movie depicting the childhood life of dr martin luther king starring oscar nominee howard rollins he directed and wrote from king to congress an award winning national television documentary on andy young’s successful bid for congress which premiered at the kennedy center  and numerous other documentaries and videos mr parrott enlisted in the united states air force serving four years prior to entering and graduating from oregon state university with bs in business administration he attended oregon state on a football scholarship under legendary hall of fame coach tommy prothro he still serves several boards including the american youth hostel peter kroll md dr peter kroll md is board certified in anesthesiology since  and board certified in pain management since  he is a founder owner and medical director of nashville tennesseebased comprehensive pain specialists the largest pain practice in the southeast with  multistate locations and over  employees specializing in the field of pain management dr kroll creates treatment and management plans for patients suffering from chronic pain resulting from a wide range of disorders diseases and complications throughout his time as a practicing physician he has directed over  clinical trials as a principal and sub investigator and authored multiple publications dr kroll graduated from loma linda university school of medicine in  in the top  of his class with academic recognition admission into the alpha omega alpha society  and through  completed his surgical internship  months of orthopedic residency and  years of anesthesiology residency at loma linda university medical center he then completed his interventional pain fellowship at wake forest university baptist hospital in  in  dr kroll graduated summa cum laude from southern adventist university collegedale tn with a ba in religion and a minor in chemistry albert röder phd dr albert röder joined genelux corporation in  after retiring from roche applied science as head of global rd and marketing support in february of that year he was elected to the board of directors of genelux corporation his distinguished year career in the pharmaceutical and diagnostics industries included several operative and leadership positions in research and development manufacturing marketing strategy and business development within international crossfunctional teams before joining roche dr röder worked for boehringer mannheim where he rose to head of research in enzymology proteinchemistry and chemistry then to head of the global product supply unit of its business unit biochemicals he holds a phd in organic chemistry from the university of tübingen in germany byron georgiou byron georgiou has had a long career in the private and public sector in business law and government service from  to  he served as one of ten bipartisan nationwide members on the financial crisis inquiry commission which conducted america’s official inquiry into the causes of the continuing financial economic and housing crises and reported its results to the president and congress httpfciclawstanfordedu byron currently oversees georgiou enterprises with wideranging interests including as chair president ceo and controlling shareholder of xtreme green electric vehicles inc wwwxgevcom manufacturer of lithium ion ironphosphate battery powered allelectric niche vehicles distributed worldwide lead investor and sole nonfounder independent director from  to  of health fusion wwwhealthfusioncom providing practice management and cloudbased healthcare information technology to us healthcare providers which was sold in  for up to  million to quality systems inc qsiinasdaq cofounder in  of and continuing advisor to corinthian capital group wwwcorinthiancapcom a new york and boston based middle market private equity fund director since  of genelux a clinical stage biopharmaceutical company that has developed a proprietary oncolytic virus based technology platform and deep pipeline of products wwwgeneluxcom director since  of nipd genetics a biotechnology company active in the field of designing developing and manufacturing noninvasive genetics tests wwwnipdcom former director of group aero wwwgroupaerocom which provided advanced engineering design and manufacturing services to the space commercial aerospace and defense markets former director of mortgage resolution partners a community advisory firm that assisted local governments in addressing the underwater mortgage crisis in america and over  year director and  cofounder with jack ford son of president gerald ford of infoplaceusa wwwinfoplaceusacom providing customer services at regional shopping centers nationwide byron has served since  on the advisory board of the harvard law school program on corporate governance wwwlawharvardeduprogramscorpgov which hosts the world’s leading blog on corporate governance and financial regulation from  to  he was of counsel to robbins geller rudman  dowd wwwrgrdlawcom and its predecessor law firms the world’s largest plaintiffs’ securities practice investigating and civilly prosecuting financial fraud with leadership roles in the historic litigations on behalf of victimized institutional investors at enron worldcom dynegy aoltimewarner and unitedhealth in  byron cofounded american partners capital group with dale hanson then ceo of the california public employees’ retirement system calpers the nation’s largest pension fund to meet the needs of institutional investors and investment managers with capital formation in a variety of alternative asset categories during the second of jerry brown’s four terms as california governor byron served as legal affairs secretary responsible for litigation by and against the governor judicial appointments liaison with the attorney general judiciary and state bar legal advice to the governor and members of his cabinet and exercise of the governor’s powers of extradition and clemency byron attended stanford university on a full alfred p sloan academic scholarship graduating with great distinction with an ab in political science as a participant in the honors program in social thought and institutions and received his jd magna cum laude from harvard law school aboutboard of directors management team advisory boards leadershiponcolytic virotherapy publications intellectual property technologyattacking cancer imaging therapies glonc vvet pipeline clinical trialsabout clinical trials clinical trials operations contactcareers copyright   genelux  disclaimer website by blausenmedia